NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
Back to search
Official data from USPTO
BREAKTHROUGH THERAPIES FOR SKIN DISEASES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BREAKTHROUGH THERAPIES FOR SKIN DISEASES
ST13
US500000098255148Class
42
Filing
98255148
Registration
7978294
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
10/08/2025
Trademark type
Word
Nice classes
42
Filing date
11/04/2023
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
01/01/2025
First use in commerce
01/01/2025
Drawing code
4
Owner type
03
Owner location
Annapolis, MD
Examiner
GEBHARDT,JACQUELINE D
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Alphyn Biologics, Inc.
Representatives
Michael J. Hertz WOODS ROGERS VANDEVENTER BLACK PLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of drugs and medicines for the treatment of infectionslung diseasesskin diseases; Research and development in the pharmaceuticallife sciencesbiomedicine fields; Scientific researchtestinganalysis in the fields of pharmaceuticalslife sciencebiomedicine; Medical and scientific research on lung diseasesskin diseasesinfectionscancer; Pharmaceutical products testinganalysisresearchdevelopment
Publications
History of USPTO decisions and trademark events.
25 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/07/2025
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
09/11/2025
IUAA
USE AMENDMENT ACCEPTED
09/11/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/19/2025
IUAF
USE AMENDMENT FILED
08/19/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/19/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/19/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/19/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/19/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/19/2025
GNFR
FINAL REFUSAL E-MAILED
02/19/2025
CNFR
FINAL REFUSAL WRITTEN
02/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2024
GNRT
NON-FINAL ACTION E-MAILED
07/10/2024
CNRT
NON-FINAL ACTION WRITTEN
07/10/2024
DOCK
ASSIGNED TO EXAMINER
06/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/28/2023
NWAP
NEW APPLICATION ENTERED
11/08/2023
Continuous trademark protection
Get notified about every new filing that threatens BREAKTHROUGH THERAPIES FOR SKIN DISEASES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.